Annual ReportHealthcare

Max Healthcare Institute Limited

MAXHEALTH.NS · Period ending 2026-03-31 · Filed 2026-03-31 · Updated

In short

Max Healthcare Institute Limited (MAXHEALTH.NS) has revenue up 19.0% to INR 82.3B and net income up 34.1% to INR 14.4B year on year. Its net margin is 17.5% and gross margin 78.2%, and it trades at 65.7× trailing earnings. Fisclear flags 1 high-severity risk, led by: Current ratio of 0.89x — short-term liabilities exceed current assets, which could create near-term liquidity pressure. How we calculate this

Valuation

Healthcare
Live · Yahoo Finance

Price

₹947.10

Market Cap

₹921.8B

P/E (TTM)

67.0x

Price ÷ earnings per share

P/B

8.1x

Price ÷ book value

P/S (TTM)

10.1x

Price ÷ revenue per share

Beta

0.18

Low volatility vs market

52-Week Range

₹797.00₹947.10 now₹1,185.40

4-engine score — Quality and Peers engines require SEC EDGAR (US stocks only)

Efficiency
56/100
Value
29/100
Cashflow
58/100
Regime
55/100

P/E 67.0× — premium valuation.

Revenue growing 19% YoY.

Based on filing period ending Mar 2026

International FisclearScore uses 4 engines (no EDGAR data). Based on Yahoo Finance & Alpha Vantage reported financials. Not financial advice.

MAXHEALTH.NS vs

🇮🇳 India Macro Indicators

Full dashboard →

Policy Rate

6.75%↑

Restrictive

USD/INR

95.472→

The India central bank policy rate stands at 6.75% — a restrictive rate environment; USD/INR is at 95.472.

SWOT Analysis — MAXHEALTH.NS

Inflationary Boom
Macro lens (Inflationary Boom): Rising costs and tighter margins amplify financial risks in this regime.
✦

Strengths

  • Net Income: INR 14.4B (+34.1% YoY) — Profit grew 34% — the company kept more of each dollar earned.

  • EPS (Diluted): INR 14.76 (+34.1% YoY) — Earnings per share rose 34% — each share earned more.

  • Revenue: INR 82.3B (+19.0% YoY) — Revenue grew 19% — the company sold more goods or services than the prior year.

  • Gross Profit: INR 64.4B (+18.4% YoY) — Gross profit rose 18% — the spread between revenue and direct costs improved.

  • Operating Cash Flow: INR 16.3B (+13.6% YoY) — Operating cash flow grew 14% — the business generated more cash from day-to-day operations.

◈

Weaknesses

No material weaknesses flagged.

◎

Opportunities

No clear opportunities identified at this time.

⚠

Threats

  • Current ratio of 0.89x — short-term liabilities exceed current assets, which could create near-term liquidity pressure.

Year-over-Year Changes

Net Income

INR 14.4B

was INR 10.8B

+34.1%

Profit grew 34% — the company kept more of each dollar earned.

EPS (Diluted)

INR 14.76

was INR 11.01

+34.1%

Earnings per share rose 34% — each share earned more.

Revenue

INR 82.3B

was INR 69.1B

+19.0%

Revenue grew 19% — the company sold more goods or services than the prior year.

Gross Profit

INR 64.4B

was INR 54.3B

+18.4%

Gross profit rose 18% — the spread between revenue and direct costs improved.

Operating Cash Flow

INR 16.3B

was INR 14.4B

+13.6%

Operating cash flow grew 14% — the business generated more cash from day-to-day operations.

Risk Flags

1 high · 0 medium · 0 low
  • ⚠ High

    Current ratio of 0.89x — short-term liabilities exceed current assets, which could create near-term liquidity pressure.

Technical Signals

Daily closes · 1-year data

Max Healthcare Institute Limited: common questions

Is Max Healthcare Institute Limited profitable?

Yes. Max Healthcare Institute Limited made a net profit of ₹14.4B in its latest fiscal year (fiscal 2026), a net margin of 17.5%.

Is Max Healthcare Institute Limited's revenue growing?

Yes. Revenue grew 19.0% year on year, to INR 82.3B.

What is Max Healthcare Institute Limited's P/E ratio?

Max Healthcare Institute Limited trades at 67.0× its trailing twelve-month earnings. In other words, the share price is about 67 times the profit per share the company earned over the past year.

Does Max Healthcare Institute Limited pay a dividend?

Yes. Max Healthcare Institute Limited's forward dividend yield is 0.21%, the expected annual dividend as a share of the current share price.

What are the main risks for Max Healthcare Institute Limited?

Fisclear's checks flag 1 medium- or high-severity risk. The most serious: Current ratio of 0.89x — short-term liabilities exceed current assets, which could create near-term liquidity pressure.

Answers are generated from the figures in this report (updated 5 Nov 2026). Information, not investment advice.

Latest News

via Finnhub

Filing History — MAXHEALTH.NS

Get the weekly digest

5 company reports + macro context every week, free. No spam.

  • Unlimited goal simulations
  • 5 free company report summaries per day
  • Weekly financial insights newsletter

External Links

Research Max Healthcare Institute Limited

Data sourced from NSE India, FRED (Federal Reserve), OECD, BIS, and Yahoo Finance. For informational purposes only. Not financial advice.